It was reported that only one-third of CTC-positive breast cancer patients, who were initially diagnosed with ER-positive primary tumours, harbored ER-positive CTCs at the time of metastasis, and, even in those patients, both ER-positive and ER-negative CTCs were found. This evidence concerns the gene ESR1 and breast carcinoma.